|
|
|
| home > news > detailed info |
|
|
 INDUSTRY NEWS AND PRESS RELEASES |
ICON Releases Environmental, Social and Governance Report |
 |
|
The report looks to the future of ESG for the new ICON while highlighting advancements made in 2020
Dublin, Ireland, November 22, 2021 — ICON plc (NASDAQ: ICLR) announced today the release of its 2020 Environmental,
Social and Governance (ESG) Report. With the completion of ICON’s
acquisition of PRA Health Sciences, the report presents a unified
overview of the ESG advancements of both legacy organisations during
2020 and sets out the commitments, policies, and outlook for the
combined company.
The ESG Report is available at: https://www.iconplc.com/about/esg/
“As a combined company, new ICON is focused on continuing to develop
its ESG strategy and initiatives,” said ICON CEO Steve Cutler. “This
report may be a look back to 2020, but it also demonstrates the great
promise of the two organisations joining together to become the
healthcare intelligence partner of choice. New ICON will continue to
make a positive social and environmental impact and pursue our ESG goals
and targets.”
For more information about ICON’s ESG efforts, please visit https://www.iconplc.com/about/esg/ |
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
ENHANC3D GENOMICS Awarded QuickFire Challenge Grant
Cambridge, UK – 26 May 2022: ENHANC3D GENOMICS (“Enhanc3D”), a
biotechnology company unlocking the full potential of the human 3D
genome to accelerate patient-centric medicine, announces it has been
selected as one of the awardees under Johnson & Johnson Innovation’s
Immunology Innovations QuickFire Challenge. The Challenge called for
innovative companies with transformative potential solutions aiming to
advance precision medicine approaches in immune-mediated disease.
Enhanc3D will receive grant funding, one year of residency at Johnson
& Johnson Innovation – JLABS, and mentorship from experts at the
Johnson & Johnson Family of Companies.
More info >> |
|
 |
White Papers |
 |
|
ConsulTech GmbH
ConsulTech GmbH
ConsulTech is a consulting company founded in 1992. Since then, we have
been supporting biotech-nology, pharmaceutical and medical technology
companies as well as research institutions with the entire process of
setting-up and executing proposals for R&D projects. In projects
funded by the European Commission, ConsulTech supports the coordinator
by resuming administrative tasks allow-ing coordinators and partners to
fully concentrate on the scientific and technical success of the
pro-ject. We solve financial and administrative issues, organise
meetings, take care of the timely delivery of milestones and reports and
much more.
More info >> |
|
 |
Industry Events |
 |
Connect in Pharma
14-15 September 2022, Plaexpo, Geneva, Switzerland
The new event driving innovation for pharma and biopharma businesses,
Connect in Pharma will unite key players in Pharmaceutical and
Biopharmaceutical packaging and production in Geneva on 14 – 15
September 2022.
More info >> |
|
|
